Shrinking lung syndrome in systemic lupus erythematosus and Sjogren's syndrome

Journal of Clinical Rheumatology

Volumn 8, Issue 6, 2002, Pages 340-345

  Singh, Ranju ^a   Huang, Wenqun ^a   Menon, Yamini ^a   Espinoza, Luis R ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti Ro (SSA) antibody; Shrinking lung syndrome; Sjogren's syndrome; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE; PREDNISONE; PROTEIN; PROTEIN SM; SALBUTAMOL; SALMETEROL; STEROID; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DYSPNEA; EARLY DIAGNOSIS; FEMALE; HEMIDIAPHRAGM; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHROTIC SYNDROME; PAROTID GLAND; PLEURISY; PRIORITY JOURNAL; PROGNOSIS; SHRINKING LUNG SYNDROME; SJOEGREN SYNDROME; STURGE WEBER SYNDROME; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0036899629     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200212000-00011     Document Type: Article

References (31)

1. Harvey AM, Shulman LE, Tumulty PA, et al. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954;33:291-437.
2. Tumulty PA. The clinical course of systemic lupus erythematosus. JAMA 1954;156:947-53.
3. Ellman P, Cudkowicz L. Pulmonary manifestations in the diffuse collagen diseases. Thorax 1954;9:46-57.
4. Hoffbrand BI, Beck ER. "Unexplained" dyspnea and shrinking lungs in systemic lupus erythematosus. BMJ 1965;1:1273-7.
5. Ishii M, Uda H, Yamagami T, et al. Possible association of "shrinking lung" and anti-Ro/SSA antibody. Arthritis Rheum 2000;43:2612-3.
6. Tavoni A, Vitali C, Cirigliano G, et al. Shrinking lung in primary Sjogren's syndrome. Arthritis Rheum 1999;42:2249-50.
7. Gibson CJ, Edmonds JP, Hughes GR. Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med 1977;63:926-32.
8. Martens J, Demedts M, Vanmeenen MT, et al. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983;84:170-5.
9. Thompson PJ, Dhillon DP, Ledingham J, et al. Shrinking lungs, diaphragm dysfunction, and systemic lupus erythematosus. Am Rev Respir Dis 1985;132:926-8.
10. Jacobelli S, Moreno R, Massardo L, et al. Inspiratory muscle dysfunction and unexplained dyspnea in systemic lupus erythematosus. Arthritis Rheum 1985;28:781-8.
11. Laroche CM, Mulvey DA, Hawkins PN, et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 1989;71:429-39.
12. Wilcox PG, Stein HB, Clarke SD, et al. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest 1988;93:352-8.
13. Hardy K, Herry I, Attali V, et al. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001;119:1274-7.
14. Shin YS, Fink H, Khiroya R, et al. Prednisolone-induced muscle dysfunction is caused more by atrophy than by altered acetylcholine receptor expression. Anesth Analg 2000;91:322-8.
15. Hughes JT, Esirl M, Oxbury JM, et al. Chloroquine myopathy. Q J Med 1971;157:85-93.
16. Chapman RS, Ewen SWB. Chloroquine-induced myopathy. Br J Dermatol 1969;81:217-9.
17. Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE: A clinical pathologic study. J Rheumatol 1983;10:973-6.
18. Stevens WM, Burdon JG, Clemens LE, et al. The "shrinking lungs syndrome": An infrequently recognised feature of systemic lupus erythematosis. Aust N Z J Med 1990;20:67-70.
19. Warrington KJ, Moder KG, Brutinel WM. The shrinking lungs in systemic lupus erythematosus. Mayo Clin Proc 2000;75:467-72.
20. Kitamura Y, Okano Y. A case of the "shrinking lung syndrome" in SLE: Improvement with corticosteroid therapy. Jpn J Clin Immunol 1996;19:217-22.
21. Walz-Leblanc BA, Urowitz MB, Gladman DD, et al. The "shrinking lungs syndrome" in systemic lupus erythematosus: Improvement with corticosteroid therapy. J Rheumatol 1992;19:1970-2.
22. Soubrier M, Dubost JJ, Piette JC, et al. Shrinking lung syndrome in systemic lupus erythematosus: A report of three cases. Rev Rhum Engl Ed 1995;62:395-8.
23. Kitamura Y, Okano Y. A case of "shrinking lung syndrome" in SLE improvement with corticosteroid therapy. Niho Rinsho Meneki Gakka Kaishi. 1996;19:217-22.
24. Hawkin P, Davison AG, Dasgupta B, et al. Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes. Thorax 2001;56:329-30.
25. Munoz-Rodriguez FJ, Font J, Badia JR, et al. Shrinking lungs syndrome in systemic lupus erythematosus: Improvement with inhaled beta-agonist therapy. Lupus 1997;6:412-4.
26. Aubier M, Viires N, Murciano D, et al. Effects and mechanism of action of terbutaline on diaphragmatic contractility and fatigue. J Appl Physiol 1984;56:922-9.
27. Van Veen S, Peeters AJ, Sterk PJ, et al. The "shrinking lung syndrome" in SLE: Treatment with theophylline. Clin Rheumatol 1993;12:462-5.
28. Aubier M. Effect of theophylline on diaphragmatic muscle function. Chest 1987;92(Suppl 1):27S-31S.
29. Bernstein RM, Ind PW, Elkon KB, et al. Pulmonary function in SLE with a longitudinal study of shrinking lungs syndrome [abstract]. Arthritis Rheum 1982;25(Suppl):S7.
30. Klippel JH, Dieppe PA. Connective Tissue Disorder: Practical Rheumatology. London: Mosby, 1995; p. 318.
31. Mirinda L, Karim Y, Tench C, et al. Clinical features and outcome of the shrinking lung syndrome in systemic lupus erythematosus. Arthritis Rheum 2001;1688(Suppl):S334.